Concourse Financial Group Securities, Inc. Pasithea Therapeutics Corp. Transaction History

Concourse Financial Group Securities, Inc.

  • $1.64 Billion
  • Q3 2024

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 07, 2024
BUY
$0.28 - $0.48 $0 - $0
0 New
0 $0
Q3 2023

Oct 30, 2023
BUY
$0.44 - $0.63 $0 - $0
0 New
0 $0
Q3 2023

Oct 25, 2023
BUY
$0.44 - $0.63 $0 - $0
0 New
0 $0
Q2 2023

Aug 10, 2023
BUY
$0.31 - $0.5 $0 - $0
0 New
0 $0
Q1 2023

May 15, 2023
BUY
$0.38 - $0.73 $0 - $0
0 New
0 $0
Q4 2022

Jan 30, 2023
BUY
$0.55 - $26.0 $0 - $0
0 New
0 $0
Q3 2022

Nov 15, 2022
BUY
$0.08 - $26.4 $0 - $0
0 New
0 $0
Q2 2022

Aug 09, 2022
BUY
$16.52 - $27.0 $0 - $0
0 New
0 $0
Q1 2022

May 09, 2022
BUY
$19.4 - $35.8 $0 - $0
0 New
0 $0
Q4 2021

Feb 07, 2022
BUY
$28.8 - $112.0 $0 - $0
0 New
0 $0
Q3 2021

Nov 09, 2021
BUY
$54.8 - $71.2 $0 - $0
0 New
0 $0

About Pasithea Therapeutics Corp.

KTTA Quotes by TradingView
  • Ticker KTTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,398,700
  • Market Cap $79.1M
  • Description
  • Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. It also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. The company was incorporated in 2020 ...
More about KTTA
Track This Portfolio

Track Concourse Financial Group Securities, Inc. Portfolio

Follow Concourse Financial Group Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email